- Delivery Method:
- Electronic Mail
Recipient NameChristine A. Givant
Recipient TitlePharmacist in Charge
- La Vita Compounding Pharmacy, LLC
3978 Sorrento Valley Boulevard
San Diego, CA 92121-1436
- Issuing Office:
- Division of Pharmaceutical Quality Operations IV
Dear Ms. Givant:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (CMS No. 575286) dated February 28, 2019. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV